System Transmission

Top Signal

100#1 JOB

Activity

2182Ripe

+938 today

System

Livenow

Terminal Asset View

stockNASDAQ

THAR

$4.07-2.98%

Tharimmune Inc. - Common Stock

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

7Overripe

Live Analysis Active

Synchronizing Data Stream

Establishing multi-vendor link for THAR

Pipeline Initializing...

System Progress0%

Low Latency Link

Encrypted Port

Company Mission

Tharimmune Inc. develops medical treatments, specifically using a skin patch to deliver drugs for liver diseases. Doctors and patients use these treatments to manage conditions like liver inflammation. The company makes money by selling these drugs and partnering with larger pharmaceutical firms for development and distribution.

THA

Industry Context

Tharimmune operates in the biotechnology industry, which focuses on developing new medical treatments through scientific research. This industry is highly competitive, with companies racing to bring innovative drugs to market. Success often depends on clinical trial results and regulatory approvals, making it a high-risk, high-reward field.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Scoring Data Pending

Our scoring engine is gathering indicator data for this asset. Component breakdowns will appear once analysis is complete.

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing THAR across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 10:10 PM UTC

Develops drugs for skin and liver diseases, aiming to generate revenue through successful clinical trials and future sales.

Price action shows consolidation near $5, suggesting potential breakout as it tests resistance. Watch for a close above this level.

Volume patterns indicate accumulation at lower prices, hinting at buyer interest because of upcoming clinical trial results. Monitor if volume spikes above average.

Biotech sector momentum is driving activity, with price holding above $4 support, signaling resilience. Watch for industry news on drug approvals.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...